For diagnosis, COPA A-to-I editing in CRC can predict immunotherapy response, while AZIN1 editing influences tumor angiogenesis via IL-8 regulation [389, 392]; elevated AZIN1 editing in GC serves as an independent risk factor for prognosis and lymph node metastasis [427]. This evidence concerns the gene AZIN1 and neoplasm.